Dr AI Jane Is on A Mission: Offering You Mr Hooman The Best Life You Can Dream Of ??
Ari Massoudi
I do stuff enabling Mankind to live longer, stronger and smarter ?????????=>??
The Unlikely Hero: The Story of Sildenafil (Viagra)
As the 20th century drew to a close, the world was on the brink of a new millennium. Amidst political scandals and economic booms, one thing captured the imagination of the First World: Sildenafil, better known as Viagra. This little blue pill promised to revolutionize the treatment of erectile dysfunction, a condition that had plagued humankind for centuries. Sildenafil's journey was fraught with initial failures and unexpected discoveries, but its eventual triumph made Pfizer billions and changed the lives of millions.
A Journey Through History
The quest to overcome impotence—the inability to achieve or maintain an erection—has been a persistent human endeavor for thousands of years. From ancient Egyptian tombs to French impotence trials, the search for a solution has been relentless. Early remedies were as varied as they were bizarre: Greeks and Romans wore talismans of rooster and goat genitalia, ate animals thought to have high libidos, and even drank the semen of hawks and eagles. In the 1200s, Albert Magnus suggested eating roasted wolf penis. King Louis XVI of France experienced impotence at age fifteen, highlighting that this issue was not confined to any particular era or social class.
The Evolution of Treatments
As medical understanding advanced, so did the techniques to combat impotence. Regnier de Graaf demonstrated the power of penile blood vessels by injecting saline into cadavers. Dr. William Hammond used electricity to stimulate erections, and Charles Edouard Brown-Séquard theorized about the role of hormones. By the early 20th century, surgical approaches and prostheses became more common, with devices like vacuum pumps and implants offering temporary relief.
The Birth of Sildenafil
Sildenafil was initially developed by Pfizer in the late 1980s as UK-92480. Researchers Peter Dunn and Albert Wood aimed to treat high blood pressure and angina by targeting the enzyme phosphodiesterase type 5 (PDE5). Initial trials were disappointing, and the project was nearly abandoned. However, an unexpected side effect emerged during trials on miners in South Wales: participants reported increased erections. This serendipitous discovery led Pfizer chemist David Brown to secure funding for an impotence study, marking the beginning of Sildenafil's second life. Sildenafil citrate, with its small citrate molecule for stability, became Viagra—a name suggesting vitality and accomplishment.
The Mechanism of Action
Sildenafil works by inhibiting phosphodiesterase type 5?(PDE5), which normally breaks down cyclic guanosine monophosphate (cGMP). cGMP is produced in response to sexual stimulation and nitric oxide release, leading to the relaxation of smooth muscle tissue and increased blood flow to the penis. By inhibiting PDE5, sildenafil allows cGMP to accumulate, prolonging the erection. This mechanism ensures that sildenafil only works in the presence of sexual stimulation, making it a safe and effective treatment for erectile dysfunction.
Marketing Genius and Cultural Impact
Pfizer's marketing strategy was a masterclass in rebranding. They replaced the stigmatized term "impotence" with "erectile dysfunction," making it more socially acceptable. The first Viagra commercial featured former presidential candidate Bob Dole, speaking openly about his struggles with erectile dysfunction. This bold move, along with sponsorships and celebrity endorsements, helped destigmatize the condition and boost Viagra's popularity.?Viagra became a cultural phenomenon, even sponsoring a NASCAR car.
Side Effects and Counterfeits
Viagra's success came with side effects like priapism and cyanopsia.
The demand for Viagra was so high that counterfeit versions flooded the market, pills?containing harmful substance like arsenic.
Despite these challenges, Viagra remained a blockbuster drug, eventually finding additional uses, such as treating pulmonary arterial hypertension under the brand name Revatio.
The Role of AI in Drug Discovery
The discovery of Sildenafil was a result of serendipity. However, the future of drug discovery lies in artificial intelligence (AI). AI can analyze vast amounts of data, identify patterns, and predict outcomes with unprecedented accuracy. If researchers had access to AI during the development of Sildenafil, the process would have been more efficient and targeted. AI could have identified the potential of UK-92480 for treating erectile dysfunction much earlier, saving time and resources.
AI's Potential Impact
If AI had been available during the development of Viagra, the story might have unfolded differently. AI could have accelerated the identification of sildenafil's potential, reducing the time and resources spent on initial failed trials. It could have predicted the drug's side effects and optimized its formulation, leading to a more targeted and effective treatment. The history of Viagra would have been one of precision and efficiency, rather than a tale of lucky accidents and perseverance.
If you're interested by AI-driven drug discovery ??????
ITW Dr. Ivan De Weber, PhD - Cofounder-CEO at Cortex Discovery
Exciting news! ?? Join us for the next episode of our LinkedIn Live podcast featuring Dr. Ivan De Weber, PhD, co-founder and CEO of Cortex Discovery, a groundbreaking startup revolutionizing drug discovery through AI!
?? From Academia to AI-Powered Drug Discovery
Dr. de Weber's journey is nothing short of inspiring. We'll explore his transition from cellular biology and pharmaceutical bioinformatics to founding a company at the cutting edge of AI-driven drug discovery. Learn how his lifelong quest for longevity research led to the creation of Cortex Discovery.
?? Unveiling Cortex Discovery's Innovative Approach
Discover how Cortex Discovery is disrupting preclinical drug discovery across all therapeutic areas with their proprietary AI models. We'll delve into:
? Their foundation model for drug property predictions
? The vast database of 750 million data points powering their deep learning system
? Recent breakthroughs, including the first AI-discovered compound proven to extend lifespan in a whole organism
?? Business Insights and Future Outlook
Get an insider's perspective on:
? Cortex Discovery's unique business model and collaboration opportunities
? Challenges faced in the AI-driven drug discovery landscape
? The company's vision for the future of longevity research and pharmaceutical development
This episode is a must-watch for:
? Biotech and pharmaceutical executives
? Investors in the life sciences sector
? Academic researchers in pharmaceutical chemistry, longevity biology, and clinical medicine
? Anyone interested in the intersection of AI and drug discovery
Don't miss this opportunity to gain valuable insights into the future of AI-powered drug discovery and longevity research. Tune in to our LinkedIn Live podcast and be part of the conversation shaping the future of medicine!